Bausch Health Companies Inc. (TSX:BHC)
Canada
· Delayed Price · Currency is CAD 9.61
-0.71 (-6.88%)
At close: Dec 5, 2025
Revenue
Fiscal year is January - December.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2015 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2015 - 2020 |
| Salix Revenue | 2.52B | 2.33B |
Log In |
Log In |
Log In | Upgrade
|
| International Rx Revenue | 1.11B | 1.11B |
Log In |
Log In |
Log In | Upgrade
|
| Solta Medical Revenue | 519.00M | 440.00M |
Log In |
Log In |
Log In | Upgrade
|
| Diversified Products Revenue | 910.00M | 950.00M |
Log In |
Log In |
Log In | Upgrade
|
| Bausch + Lomb Revenue | 4.98B | 4.79B |
Log In |
Log In |
Log In | Upgrade
|
| Ortho Dermatologies Revenue | - | - |
Log In |
Log In |
Log In | Upgrade
|
| Revenue (Other) | -755.58M | -1.84B |
Log In |
Log In |
Log In | Upgrade
|
| Revenue (Total) | 9.27B | 7.78B |
Log In |
Log In |
Log In | Upgrade
|
EBIT
Fiscal year is January - December.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2015 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2015 - 2020 |
| Salix Segment Profit | 1.86B | 1.60B |
Log In |
Log In |
Log In | Upgrade
|
| International Rx Segment Profit | 351.00M | 376.00M |
Log In |
Log In |
Log In | Upgrade
|
| Solta Medical Segment Profit | 250.00M | 213.00M |
Log In |
Log In |
Log In | Upgrade
|
| Diversified Products Segment Profit | 605.00M | 626.00M |
Log In |
Log In |
Log In | Upgrade
|
| Bausch + Lomb Segment Profit | 1.04B | 1.11B |
Log In |
Log In |
Log In | Upgrade
|
| Ortho Dermatologies Segment Profit | - | - |
Log In |
Log In |
Log In | Upgrade
|
| Operating Income (Other) | -2.38B | -2.64B |
Log In |
Log In |
Log In | Upgrade
|
| Operating Income (Total) | 1.72B | 1.29B |
Log In |
Log In |
Log In | Upgrade
|